ABVC BioPharma, Inc. Derivative, Collateral, Right to Reclaim Cash
ABVC BioPharma, Inc. (ABVC) had Derivative, Collateral, Right to Reclaim Cash of $2.40 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Notes
us-gaap:DerivativeCollateralRightToReclaimCash · last filed 2023-08-14
- 2023-06-30: Derivative, Collateral, Right to Reclaim Cash $2.40M.
- 2023-03-31: Derivative, Collateral, Right to Reclaim Cash $1.50M.
- 2022-09-30: Derivative, Collateral, Right to Reclaim Cash $7.40M.
| Period end | Derivative, Collateral, Right to Reclaim Cash |
|---|---|
| 2023-06-30 | $2.40M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $1.50M 10-Q · filed 2023-05-15 |
| 2022-09-30 | $7.40M 10-K · filed 2023-03-31 |